Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Human serum RNase-L level is inversely associated with metabolic syndrome and age.

Wang YT, Tseng PH, Chen CL, Han DS, Chi YC, Tseng FY, Yang WS.

Cardiovasc Diabetol. 2017 Apr 11;16(1):46. doi: 10.1186/s12933-017-0522-x.

2.
3.

Metabolic syndrome and renal cell carcinoma.

Zhang GM, Zhu Y, Ye DW.

World J Surg Oncol. 2014 Jul 29;12:236. doi: 10.1186/1477-7819-12-236. Review.

4.

Insulin resistance and serum levels of interleukin-17 and interleukin-18 in normal pregnancy.

Jahromi AS, Shojaei M, Ghobadifar MA.

Immune Netw. 2014 Jun;14(3):149-55. doi: 10.4110/in.2014.14.3.149. Epub 2014 Jun 19.

5.

Is Alzheimer's disease a systemic disease?

Morris JK, Honea RA, Vidoni ED, Swerdlow RH, Burns JM.

Biochim Biophys Acta. 2014 Sep;1842(9):1340-9. doi: 10.1016/j.bbadis.2014.04.012. Epub 2014 Apr 18. Review.

6.

Relationship between obesity, adipocytokines and inflammatory markers in type 2 diabetes: relevance for cardiovascular risk prevention.

Rajkovic N, Zamaklar M, Lalic K, Jotic A, Lukic L, Milicic T, Singh S, Stosic L, Lalic NM.

Int J Environ Res Public Health. 2014 Apr 14;11(4):4049-65. doi: 10.3390/ijerph110404049.

7.

Hypertension in obese type 2 diabetes patients is associated with increases in insulin resistance and IL-6 cytokine levels: potential targets for an efficient preventive intervention.

Lukic L, Lalic NM, Rajkovic N, Jotic A, Lalic K, Milicic T, Seferovic JP, Macesic M, Gajovic JS.

Int J Environ Res Public Health. 2014 Mar 28;11(4):3586-98. doi: 10.3390/ijerph110403586.

8.

Elevated peripheral frequencies of Th22 cells: a novel potent participant in obesity and type 2 diabetes.

Zhao R, Tang D, Yi S, Li W, Wu C, Lu Y, Hou X, Song J, Lin P, Chen L, Sun L.

PLoS One. 2014 Jan 17;9(1):e85770. doi: 10.1371/journal.pone.0085770. eCollection 2014.

9.

Inverse correlation of serum inflammatory markers with metabolic parameters in healthy, Black and White prepubertal youth.

Zabaleta J, Velasco-Gonzalez C, Estrada J, Ravussin E, Pelligrino N, Mohler MC, Larson-Meyer E, Boulares AH, Powell-Young Y, Bennett B, Happel K, Cefalu W, Scribner R, Tseng TS, Sothern M.

Int J Obes (Lond). 2014 Apr;38(4):563-8. doi: 10.1038/ijo.2013.220. Epub 2013 Nov 26.

10.
11.

The role of chronic inflammation in obesity-associated cancers.

Ramos-Nino ME.

ISRN Oncol. 2013 May 30;2013:697521. doi: 10.1155/2013/697521. Print 2013.

12.

Endocrine and metabolic changes in human aging.

Banks WA, Morley JE.

J Am Aging Assoc. 2000 Apr;23(2):103-15. doi: 10.1007/s11357-000-0011-z.

13.

Tumor necrosis factor-α: regulation of renal function and blood pressure.

Ramseyer VD, Garvin JL.

Am J Physiol Renal Physiol. 2013 May 15;304(10):F1231-42. doi: 10.1152/ajprenal.00557.2012. Epub 2013 Mar 20. Review.

14.

Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.

Mirrakhimov AE.

Cardiovasc Diabetol. 2012 Oct 27;11:132. doi: 10.1186/1475-2840-11-132. Review.

15.

Etiopathogenesis of nonalcoholic steatohepatitis: role of obesity, insulin resistance and mechanisms of hepatotoxicity.

Guturu P, Duchini A.

Int J Hepatol. 2012;2012:212865. doi: 10.1155/2012/212865. Epub 2012 Jun 25.

16.

Circulating levels of TNF-α are associated with impaired glucose tolerance, increased insulin resistance, and ethnicity: the Insulin Resistance Atherosclerosis Study.

Olson NC, Callas PW, Hanley AJ, Festa A, Haffner SM, Wagenknecht LE, Tracy RP.

J Clin Endocrinol Metab. 2012 Mar;97(3):1032-40. doi: 10.1210/jc.2011-2155. Epub 2012 Jan 11.

17.

The link between the metabolic syndrome and cancer.

Braun S, Bitton-Worms K, LeRoith D.

Int J Biol Sci. 2011;7(7):1003-15. Epub 2011 Aug 16. Review.

18.

Effect of weight loss on adipokine levels in obese patients.

Rolland C, Hession M, Broom I.

Diabetes Metab Syndr Obes. 2011;4:315-23. doi: 10.2147/DMSO.S22788. Epub 2011 Aug 3.

19.

Association between TNF-α promoter G-308A and G-238A polymorphisms and obesity.

Hedayati M, Sharifi K, Rostami F, Daneshpour MS, Zarif Yeganeh M, Azizi F.

Mol Biol Rep. 2012 Feb;39(2):825-9. doi: 10.1007/s11033-011-0804-4. Epub 2011 May 11.

20.

Surrogate markers of insulin resistance: A review.

Singh B, Saxena A.

World J Diabetes. 2010 May 15;1(2):36-47. doi: 10.4239/wjd.v1.i2.36.

Supplemental Content

Support Center